Showing 1721-1730 of 2526 results for "".
- Corxel and Lenz Therapeutics Announce Positive Phase 3 Trial Results for Presbyopia Eye Drop LNZ100 in Chinahttps://modernod.com/news/corxel-pharmaceuticals-and-lenz-therapeutics-announce-positive-phase-3-trial-results-for-presbyopia-eye-drop-lnz100-in-china/2482519/Lenz Therapeutics and its parner Corxel Pharmaceuticals unveiled phase 3 trial results from the China-based JX07001 study, showing that LNZ100, an aceclidine-based eye drop, achieved significant improvement in near vision for presbyopia patients. The study's topline results demonstr
- Epion Presents Survey on Keratoconus Highlighting Need for Accessible Treatmentshttps://modernod.com/news/epion-presents-survey-on-keratoconus-highlighting-urgent-need-for-accessible-treatments/2482518/Jonathan H. Talamo, MD, Chair of the Board at Epion Therapeutics, presented findings at the Eyecelerator@AAO 2024 conference on the current state of keratoconus (KC) management in the United States, highlighting a critical gap in treatment for the progressive eye disease. Results f
- Ocuphire Acquires Gene Therapy Company Opus Geneticshttps://modernod.com/news/ocuphire-acquires-gene-therapy-company-opus-genetics/2482508/Ocuphire Pharma announced an all-stock acquisition of Opus Genetics, a clinical-stage gene therapy company specializing in inherited retinal diseases (IRDs). As part of the deal, the combined company will be renamed Opus Genetics, effective October 23, 2024, and will begin trading under the
- Exponential Increase in Anti-VEGF Treatments Linked to Higher Risk of Complications in Cataract Surgery, Study Findshttps://modernod.com/news/exponential-increase-in-anti-vegf-treatments-linked-to-higher-risk-of-complications-in-cataract-surgery-study-finds/2482498/In the largest study of its kind, Canadian researchers from the University of Toronto have identified a higher risk of complications in cataract surgery patients with a history of anti-VEGF injections. These findings will be presented this week at AAO 2024, the 128th annual meeting of the America
- Alcon to Showcase Latest Innovations at AAO 2024 Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-at-aao-2024-annual-meeting/2482489/Alcon will unveil its latest clinical data and product innovations at the American Academy of Ophthalmology (AAO) 2024 annual meeting. Attendees, including ophthalmologists, surgical staff, researchers, and industry leaders, are invited to visit Alcon at booth #4008 for hands-on demonstrations an
- Heidelberg Engineering Receives FDA Clearance for Spectralis Flex Module for Supine Imaginghttps://modernod.com/news/heidelberg-engineering-receives-fda-clearance-for-spectralis-flex-module-for-supine-imaging/2482486/Heidelberg Engineering has received FDA clearance for its Spectralis Flex Module, a multimodal diagnostic imaging platform. The new module is designed specifically for imaging the posterior segment of both pediatric and adult patients in a supine position, addressing a need for patients unab
- Zeiss to Showcase New Digital AI Tools and Surgical Solutions at AAOhttps://modernod.com/news/zeiss-to-showcase-new-digital-ai-tools-and-surgical-solutions-at-aao/2482479/Zeiss will unveil a range of digital enhancements and surgical solutions at the American Academy of Ophthalmology (AAO) conference, running from October 19-21, 2024, in Chicago. These innovations span cataract, corneal refractive, retina, and glaucoma workflows, offering a digitally connecte
- Novaliq and Laboratoires Théa Announce EU Approval for Vevizye for Dry Eye Diseasehttps://modernod.com/news/novaliq-and-laboratoires-thea-announce-partnership-and-eu-approval-for-vevizye/2482466/Novaliq and Laboratoires Théa announced the European Commission’s approval of Vevizye (ciclosporin 0.1% eye drops solution) for the treatment of moderate to severe dry eye disease (DED) in adults unresponsive to tear substitutes. Vevizye is based on Nova
- AAOF and Meta Reality Labs Launch $1.5 Million Open-Science Initiative to Study Myopia and Visual Experiencehttps://modernod.com/news/aaof-and-meta-reality-labs-launch-15-million-open-science-initiative-to-study-myopia-and-visual-experience/2482454/The American Academy of Optometry Foundation (AAOF) has partnered with Meta Reality Labs to fund an open-science research initiative aimed at understanding the relationship between visual experience and the onset and progression of myopia. This collaboration will support three independent researc
- Oculis and Euretina Announce Winner of Inaugural Ramin Tadayoni Awardhttps://modernod.com/news/oculis-and-euretina-announce-winner-of-inaugural-ramin-tadayoni-award/2482449/Oculis, in partnership with Euretina, has announced the first recipient of the Ramin Tadayoni Award: Dr. Andrea Govetto, MD, PhD. The award honors the memory of Oculis' late Chief Scientific Officer and renowned retina specialist, Professor Ramin Tadayoni, MD, who passed away unexpectedly ear